Mallinckrodt Teams with Zydus

APRIL 01, 2005

Mallinckrodt Pharmaceuticals Generics has entered into a strategic alliance with Zydus Cadila's US subsidiary, Zydus Pharmaceuticals Inc. The agreement calls for Mallinckrodt Pharmaceuticals Generics to market and sell products under a shared Mallinckrodt-Zypharma label. The products will be developed and registered by Zydus Pharmaceuticals and will be manufactured by Zydus Cadila at its US FDA-approved manufacturing plant in Ahmedabad, India.

By melding Mallinckrodt's marketing and distribution networks with Zydus Cadila's product development and manufacturing success, Mallinckrodt expands its product portfolio and pipeline.



SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.